Guild Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,862
Closed -$249K 74
2021
Q1
$249K Buy
+6,862
New +$244K 0.27% 60
2019
Q2
Sell
-74,581
Closed -$3M 47
2019
Q1
$3M Buy
+74,581
New +$2.99M 3.92% 8
2017
Q2
Sell
-127,892
Closed -$4.15M 30
2017
Q1
$4.15M Buy
+127,892
New +$4.03M 4.04% 6

Other funds holding PFE

Guild Investment Management's PFE Position: Q2 2021 in Review

Guild Investment Management sold out of Pfizer (PFE) in Q2 2021, closing a stake of 6,862 shares — an estimated $249K sold.

Guild Investment Management first reported a position in PFE in Q1 2017 and held it in 3 quarters. The position peaked at $4.15M in Q1 2017. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Guild Investment Management reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
  • Guild Investment Management sold 6,862 Pfizer shares in Q2 2021, an estimated $249K.
  • Guild Investment Management first reported a position in Pfizer in Q1 2017 and held it in 3 quarters.
  • Guild Investment Management's Pfizer position peaked at $4.15M in Q1 2017.
  • 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Guild Investment Management's 13F filing for Q2 2021, filed 28 Jul 2021.